 Los Angeles, California--Newsfile Corp. - June 18, 2021 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Akebia Therapeutics, Inc. Akebia or the Company NASDAQ: AKBA who formerly held shares of Keryx Biopharmaceuticals, Inc. KERX for violations of the securities laws.If you are a shareholder, click here to participate.We also encourage you to contact Brian Schall of the Schall Law Firm, 2049... 